Stock screenerAll disclosures →
EDGAR →
HURA
Conviction 59HealthcareScan · Tue, Sep 8, 2026HURA$2.12-0.93%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 203.92K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price2.12
Change-0.93%
Gap-0.47%
Rel volume1.46×
Avg volume291.94K
Avg $ vol645.62K
SMA 202.18
SMA 502.21
SMA 2001.82
Price vs 50-4.11%
Price vs 200+16.58%
MA stackmixed
50/200 cross—
Supertrenddown · 2.48
RSI (14)48
MACD hist-0.00
MACD cross—
Stoch %K / %D41 / 34
ADX (14)14
+DI / −DI16 / 17
RSI divergence—
MACD divergence—
ATR %+6.63%
ADR %7.51%
52w high3.15
52w low0.4400
From 52w high-32.70%
Above 52w low+381.82%
New 52w highNo
SqueezeOff
Bollinger width21.27%
%B0.38
Donchian pos22.03%
Donchian high2.58
Donchian low1.99
AVWAP (52w high)2.41
vs AVWAP high-11.89%
AVWAP (52w low)1.81
vs AVWAP low+16.93%
OBV trendFlat
Chaikin MF (20)-0.20
Today vs 20d1.46×
Avg vol (14d)203.92K
Avg vol (20d)291.94K
Avg $ vol (20d)645.62K
Market cap135.1M
RS 3m (vs SPY)+4.48%
RS 6m (vs SPY)+28.12%
RS line new highNo
Trend template5/8
Technical rank63.2
1 week-0.47%
1 month-0.47%
3 months+3.67%
6 months+25.44%
1 year-16.86%
YTD+182.86%
P/E-4.50
P/B7.30
P/S—
P/FCF-4.88
EPS-0.6300
Div yield—
ROE-162.44%
ROA-94.66%
Debt/Eq0.01
Current0.18
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-38.60%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value134.35M
Revenue0
Net income-9.22M
Gross profit—
Free cash flow-27.71M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees22
ListedFri, Oct 18, 2024
Free float24.29M
Float %38.1%
Short interest6.32M
Days to cover21.0d
Short volume42.3%
Squeeze score73 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction59 / 100
Pattern quality—
Tech rank63.2 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.44
Support2.00
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment ConferencePR Newswire · Tue, Sep 8, 2026
- TuHURA Biosciences, Inc./NV: New debt obligationSEC EDGAR · Fri, Sep 4, 2026
Congress activity
Disclosed STOCK Act trades in HURA · 3 recent
Insider activity
SEC Form 4 transactions in HURA · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bianco James A. Chief Executive Officer · Common Stock · 2026-05-28 | Gift | 150K | $0 | 2026-05-28 | 2026-05-29 |
SEC filings
EDGAR filings in HURA · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.